The FDA has given genomics firm Helix a wider emergency use authorization (EUA) for its pandemic test. The U.S. regulator said Helix is now allowed to offer its virus test for on-site and unsupervised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback